These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7724024

  • 1. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G, Ben Maadi A, Remy P, Lang P, Lagrue G, Weil B.
    Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG, Tishkov I, Nikolov D.
    Nephrol Dial Transplant; 1994; 9(2):138-43. PubMed ID: 8190328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
    Gansevoort RT, Heeg JE, Vriesendorp R, de Zeeuw D, de Jong PE.
    Nephrol Dial Transplant; 1992; 7 Suppl 1():91-6. PubMed ID: 1337189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
    Masunaga Y, Tabei K, Takeda S, Ando Y, Kusano E, Asano Y.
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
    [Abstract] [Full Text] [Related]

  • 12. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA, Giménez Llort A, García García L, Jiménez González R.
    An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
    [Abstract] [Full Text] [Related]

  • 13. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
    Clin Nephrol; 1999 Aug; 52(2):67-75. PubMed ID: 10480216
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
    Haas M, Mayer G, Wirnsberger G, Holzer H, Ratschek M, Neyer U, Neuweiler J, Kramar R, Schneider B, Breiteneder-Geleff S, Regele HM, Hörl WH, Kerjaschki D.
    Wien Klin Wochenschr; 2002 Feb 28; 114(4):143-7. PubMed ID: 12060980
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
    Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
    Nephrol Dial Transplant; 2008 Aug 28; 23(8):2546-51. PubMed ID: 18308774
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.